Secondary GBM is associated with other genetic changes such as isocitrate dehydrogenase 1 (IDH1) and TP53 mutations, methylation of the O6-methylguanine-DNA methyltransferase (MGMT) promoter, and chromosome 19q loss. Here, MGMT is linked to glioblastoma.